Read more
10:47 AM · 30 July 2025

Chart of the day - Ethereum (30.07.2025)

Yesterday, the U.S. Securities and Exchange Commission (SEC) approved the creation and redemption of shares in Bitcoin and Ethereum ETFs in “in-kind” form, meaning investors can directly exchange cryptocurrencies for ETF shares and vice versa, without the need for cash settlements. The decision took effect following a vote on July 29, 2025.

This change—aligned with the standard model used in commodity-based ETFs—is designed to improve capital efficiency, reduce tax burdens for institutional investors, narrow bid-ask spreads, and deepen liquidity in the crypto market.

It marks a breakthrough in how crypto ETFs function, bringing them closer to traditional ETFs. Analysts expect this to attract new institutional capital and pave the way for additional products based on altcoins like Solana or Cardano, which could be structured from the outset with in-kind settlement capabilities.

Ethereum Outpaces Bitcoin: Capital Inflows and Price Surge

In recent weeks, Ethereum has gained traction and is now rivaling Bitcoin in popularity. Institutional adoption is accelerating, with public companies like BitMine Immersion and SharpLink allocating significant funds to purchase ETH.

Combined with record ETF inflows, rising interest in staking, and a favorable regulatory environment, Ethereum's clear momentum is reflected in its rapidly increasing valuation. Since the beginning of July, ETH has surged 55% to $3,822, still trading below its all-time high above $4,800.

14 April 2026, 4:30 PM

BREAKING: US PPI comes in weaker than expected. EURUSD gains ground

14 April 2026, 3:47 PM

JP Morgan earnings: Good, but it could have been better

14 April 2026, 3:13 PM

BlackRock earnings: Dynamic growth in the first quarter

14 April 2026, 3:07 PM

🚩 US NFIB report much weaker than expected

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.